Crossmark

Gene therapy as an innovative approach to the treatment of hemophilia B—a review

Crossref DOI link: https://doi.org/10.1007/s13353-025-00952-w

Published Online: 2025-04-03

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wróblewska, Kinga https://orcid.org/0000-0002-8740-9401
Bieszczad, Dominika https://orcid.org/0009-0005-1475-617X
Popławska, Magdalena https://orcid.org/0009-0007-0043-780X
Ziętara, Karolina Joanna https://orcid.org/0000-0002-6754-9263
Zajączkowska, Monika https://orcid.org/0000-0001-6545-4546
Filip, Agata https://orcid.org/0000-0001-7591-5887
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 29 July 2024

Revised: 23 November 2024

Accepted: 12 February 2025

First Online: 3 April 2025

Declarations

:

: The authors declare no competing interests.